From April 9 to 12, 2026, CMEF 2026—one of the world’s largest medical equipment exhibitions—took place in Shanghai, China, bringing together tens of thousands of businesses and healthcare experts from around the globe. Participating in this year’s event, Benovas Medical Devices JSC (BMD) continued to affirm its international integration strategy and proactive approach to exploring new product development opportunities.
At CMEF 2026, BMD set out several strategic objectives, with a key focus on identifying opportunities to develop new products in the medical consumables segment—a high-potential field that also demands increasingly stringent technical and quality standards. By directly accessing global technology trends, advanced manufacturing models, and international market demands, BMD aims to quickly adapt and apply these insights to its operations in Vietnam.
At the same time, the company is actively seeking reputable OEM partners to expand its product portfolio. In the near term, BMD plans to import and distribute essential medical consumables such as dialysis filters, bloodlines, IV cannulas, and catheters. These products are in high demand within healthcare systems and play a critical role in supporting effective patient treatment and care.
A key activity during the exhibition was BMD’s direct visits to OEM manufacturing facilities. This allowed the company to assess production capacity, quality standards, and operational processes of potential partners—an essential step to ensure that future collaborations meet strict requirements for safety and performance.
Beyond that, participation in CMEF also provided BMD with opportunities to expand its supply network for raw materials and components. The company actively explored partnerships with suppliers of plastic resins such as PP, PVC, and PET, as well as providers of assembly components and packaging materials, including films, blister paper, and IV bag pouches. Securing a stable supply chain not only ensures production continuity but also enhances the quality of finished products.
Attending CMEF 2026 marks a concrete step in BMD’s strategy to broaden its product portfolio and strengthen global connections. Through direct engagement with partners, factory visits, and exposure to the manufacturing ecosystem, the company has identified new directions for the next phase—from product development to technology investment and supply chain optimization.
The outcomes of the event go beyond trade promotion, laying a solid foundation for BMD to accelerate the implementation of its strategic plans and gradually reinforce its position in the medical consumables industry.
